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Abstract Thionins are antimicrobial plant peptides
produced as preproproteins consisting of a signal
peptide, the thionin domain, and a so-called acidic
domain. Only thionin itself has been isolated from
plants. To study the processing of the precursor, it has
to be produced in a heterologous system. Since both
domains contain several cysteines and, due to the
known antimicrobial activity of the thionin, we tested
the expression of all four Arabidopsis proproteins as
fusion proteins. Periplasmic expression as fusion with
maltose binding protein was not successful but
cytoplasmic expression as His-tagged TRX fusion
proteins with a TEV recognition sequence resulted in
proteins of correct size. Use of the SHuffle strain
C3030 further improved the expression. Fusion
proteins inhibited growth of Escherichia coli. They
could be cleaved by TEV protease, releasing authentic
proproteins without any additional amino acid at the
N-terminus.
Keywords Fusion protein  His-tag  Maltose-
binding protein  Tobacco etch virus  Thionin 
Thioredoxin
Introduction
Thionins are plant antimicrobial peptides (AMP) that
are generally basic. They contain approximately 45
amino acids and 6 or 8 cysteine residues which form
disulfide bridges (see Bohlmann 1994). Their general
structure is that of two small a-helices and two small
antiparallel b-sheets stabilized by three or four disul-
fide bridges (Stec 2006). Their toxicity and antimi-
crobial activity seem to depend on the destruction of
membranes.
Thionins have been isolated as 5 kDa peptides from
various plant species but they are synthesized as much
larger preproproteins (Ponz et al. 1986). This has been
confirmed by the cloning of different thionin cDNAs
and genomic clones showing that all precursors consist
of a typical N-terminal signal sequence, the thionin
itself, and a C-terminal acidic domain. Most acidic
domains have six cysteine residues (Fig. S1) and are
usually acidic (as the name indicates). A protein
corresponding to an acidic domain of a thionin
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precursor has never been isolated from plants. To date,
there is no experimental information available about
possible functions of the acidic domain.
The model plant, Arabidopsis thaliana, contains
four thionin genes that are expressed in different
tissues and organs of the plant. To test the antimicro-
bial activity in vitro it will be necessary either to
isolate the peptides from Arabidopsis or to produce
them in an expression system. Isolating the thionins
from Arabidopsis would require large amounts of
material. Furthermore, thionin proproteins and acidic
domain peptides might be directly processed after
synthesis and have not been isolated from any plant
species. We were therefore interested to produce
thionin proproteins in Escherichia coli. Since previous
observations (H Bohlmann unpublished results) indi-
cated that the proproteins also might have antimicro-
bial activity, we decided to produce them as fusion
proteins. Thionins and the acidic domain contain
several cysteine residues and disulfide bridges are not
easily formed within the E. coli cytoplasm. We,
therefore, first tested the expression of the proproteins
as fusions with the maltose-binding protein (MBP) by
secretion into the periplasm. We compared this to the
expression as thioredoxin (TRX) fusion proteins that
are produced in the cytoplasm.
Methods
E. coli strains (Supplementary Table 1)
We used the DH10B strain for cloning. For protein
expression, constructs in pJOE-SP-MCS vectors were
transformed into Rosetta (Novy et al. 2001) while
pETtrx_1a derived vector constructs were expressed
in Rosetta(DE3)pLysS (Novy et al. 2001) and the
SHuffle strain C3030 (Lobstein et al. 2012).
Protein quantification
Proteins were quantified with the Pierce BCA protein
assay kit. Protein concentration was measured at 562 nm
with a micro-plate reader using BSA as standard.
Digestion with tobacco etch virus protease (TEV)
We used a mutated TEV protease (TEVSH) which was
expressed and purified as described by (van den Berg
et al. (2006). Purified fusion proteins were incubated
with TEV protease at 30 C for 16 h to release
C-terminal thionin proproteins (for sequences see
Supplementary Fig. 1). To test the effect of reducing
agents on digestion efficiency, DTT (at 1 mM) or
reduced glutathione/oxidized glutathione (at 3 and
0.3 mM, respectively) were added to the standard
digestion buffer (50 mM Tris/HCl, pH 8.0, 0.5 mM
EDTA).
Gel electrophoresis
For fusion of MBPs, polyacrylamide gels (10 % v/v
separating and 4 % v/v stacking gel) were used. TRX-
fusion protein samples were resolved on Tricine/SDS
polyacrylamide gels (16 % v/v separating and 4 % v/v
stacking gel) (Scha¨gger 2006).
Western blotting
A 16 % (v/v) Tricine/SDS gel was run along with a
prestained marker (Thermo Fisher Scientific) and was
transferred to a Protran-nitrocellulose membrane
(Schleicher and Schuell BioSciences, Germany). The
transfer time for 25 kDa peptides was 20 min at 10 V.
After transfer the membrane was incubated with an
rabbit anti-6HIS epitope tag antibody (Rockland,
USA) at 1:3000 dilution. Anti-rabbit IgG antibody
(Vector Laboratories, Inc) at 1:2000 dilution was used
as secondary antibody. Immunoreactive proteins were
visualized by reaction with 5-bromo-4-chloro-3-indolyl
phosphate/nitro-blue tetrazolium.
Activity test
Purified (TRX)-fusion proteins were dialysed against
water using a dialysis membrane with a MW cut-off of
10,000. E. coli Rosetta strain was grown in LB broth.
In 96 well microtitre plates, 150 ll cells at OD600 of
0.05 were combined with 50 ll protein. Final con-
centrations of fusion proteins in growth medium were
100, 50, 25, 12.5, 6.25 and 3.125 lg/ml. Kanamycin at
50 lg/ml was used as a positive control while 50 ll
water was used as negative control. The plate was
incubated at 37 C in a plate-reader with occasional
shaking for 15 s and OD600 measurement every
30 min for 8 h.




For the expression of thionin proproteins we wanted to
use periplasmic expression since this can produce
reasonable amounts of fusion proteins as fusions with
protein A (Epple et al. 1997) or MBP (Romero et al.
1997). Protein A has the disadvantage that it binds
immunoglobulins and we therefore decided to use
MBP as a fusion partner. The plasmid pJOE4905.1
contains a rhamnose-inducible promoter which is
tightly regulated (Motejadded and Altenbuchner
2009). It contains the MalE gene coding for MBP as
a fusion partner. Six histidines for affinity purification
are located between the MBP and a codon optimised
small ubiquitin-related modifier (SUMO) domain,
which provides a recognition site for SUMO protease.
For periplasmic expression we introduced a signal
peptide (Fikes et al. 1987) as described in Supple-
mentary methods. Furthermore, we introduced a small
polylinker which allowed us to use BamHI after the
stop codon (Supplementary Fig. 2). We fused the
proproteins to the SUMO domain without any linker
such that after cleavage no additional amino acid
would remain at the N-terminus of the proprotein
(Fig. 1). All coding sequences for the Arabidopsis
thionin proproteins were introduced into this vector
and confirmed by sequencing.
In all cases a 58 kDa protein was produced after
induction while the expected size was 65 kDa (Supple-
mentary Table 2). Periplasmic proteins were isolated by
an osmotic shock procedure, but 65 kDa proteins were
clearly visible for proTHI2.1 only while a very faint band
for proTHI2.2 was detected. The majority of the fusion
proteins remained in the insoluble fraction (Supplemen-
tary Fig. 3, lanes 4). From the periplasmic protein extract
the fusion proteins were enriched by Ni–NTA affinity
chromatography but only part of the fusion proteins was
recovered as the fusion proteins were also detected in
the flow through of the column (Supplementary Fig. 3,
lanes 5), perhaps due to weak binding of the His-tag
which is located in the middle of the fusion protein. Loss
of fusion protein in the flow-through was reported by
Motejadded and Altenbuchner (2009). In addition, a large
part of the fusion protein was insoluble. We did not test if
this fraction remained in the cytoplasm or/and formed
inclusion bodies in the periplasm. The only fusion protein
that was expressed in larger amounts was the proTHI2.1
fusion protein. The highest yield (Table 1) was obtained
for proTHI2.1 (1.4 mg/l). However, it has to be consid-
ered that the largest part of these protein fractions will be
the 58 kDa protein. A Western blot of the purified protein
fractions (Supplementary Fig. 4) also showed that only
for proTHI2.1 a fusion protein of the expected size was
obtained, although in a very small amount. In all fractions
the 58 kDa band was clearly visible on the Coomassie
stained gel but was not labeled by the antibody. Instead,
the antibody very strongly labeled a 39 kDa band which
was not visible by Coomassie staining. We did not try to
determine the nature of the 58 and the 39 kDa proteins.
Since insufficient amounts of fusion proteins were
obtained, we also did not test cleavage of the fusion
proteins with SUMO protease.
Cytoplasmic expression
The periplasmic expression of the thionin proprotein
fusion proteins resulted in very low amounts of fusion
proteins which mostly did not seem to be of the correct
size and was abandoned. We therefore tested the
expression of all 4 thionin proproteins as fusions to
TRX (Bogomolovas et al. 2009) in the vector
pETtrx_1a (Fig. 1). All constructs were transformed
into the Rosetta(DE3)pLysS strain. After induction
with IPTG strong extra bands of the expected size
(25–26 kDa, Supplementary Table 3) were detected
on tricine-SDS gels (Supplementary Fig. 5). However,
a large part of the fusion proteins was again insoluble.
After lysis and centrifugation, the largest amount of
the fusion proteins was found in the pellets in all cases
(Supplementary Fig. 5, lanes 3 and 4). Ni–NTA
chromatography gave higher yields of the fusion
proteins as compared to periplasmic expression with
proTHI2.1 having the highest yield as compared to the
other thionin proproteins (Table 1). We separated all
four purified TRX fusion proteins side-by-side on one
gel and used an antibody against the His-tag to detect
Fig. 1 Schematic diagrams of the expression cassettes for
thionin proproteins. Top, pJOE-SP-MCS for expression in the
periplasm of E.coli. Bottom, Plasmid pETtrx-1a for expression
in the cytoplasm of E.coli. HIS his-tag; MBP maltose binding
protein, SP signal peptide, SUMO small ubiquitin related
modifier, TEV TEV protease recognition sequence, THI thionin
proprotein, TRX thioredoxin
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the fusion proteins on a Western blot (Supplementary
Fig. 6). The proTHI2.2 fusion showed several small
bands at around 15, 14, and 10 kDa that were not seen
with the other fusion proteins. These were also labeled
with the anti-His-tag antibody and seemed to be
degradation products. Western blotting with the anti-
His-tag antibody also detected a large band in the
proTHI2.1 fraction at around 60 kDa and a smaller
(20 kDa) and larger band (30 kDa) in the proTHI2.3
fraction.
The cytoplasm of E. coli is not well suited for the
production of proteins containing disulfide bridges.
However, E. coli strains with an oxidizing cytoplasm
have been reported that result in high levels of
functional proteins with disulfide bridges. We there-
fore cloned the expression plasmids for all four fusion
proteins into the SHuffle strain C3030 (New England
Biolabs) in which the lethal phenotype of lacking the
gor and trxB reductases is suppressed by a mutation in
the peroxidase ahpC (Faulkner et al. 2008) thus
providing an oxidising environment in the cytoplasm.
Additionally, expression of periplasmic disulfide bond
isomerase (DsbC) in the cytoplasm of these strains is
supposed to enhance proper disulfide bond formation
(Maskos et al. 2003). We induced the expression with
IPTG and separated the crude protein extract into
soluble and insoluble proteins by centrifugation
(Fig. 2). Again, only a small part of the proTHI2.2
and proTHI2.4 fusion protein was soluble. However,
the fraction of soluble fusion protein was larger than
that of the Rosetta strain (Supplementary Fig. 5). The
amount of fusion protein that could be produced from
the SHuffle strain C3030 is shown in Table 1 and was
higher than obtained with Rosetta(DE3)pLysS. Wes-
tern blotting of the purified fusion proteins (Fig. 3)
showed less contaminating proteins than with the
Rosetta(DE3)pLysS strain (Supplementary Fig. 6).
Only the proTHI2.2 fusion protein showed a promi-
nent extra band on the Western blot which was a few
kDa larger than the fusion protein.
TEV digestion of the fusion proteins
All fusion proteins produced with the pETtrx_1a
vector were digested with TEV protease. Since the
Table 1 Quantification of fusion proteins
Proprotein MBP—fusion TRXfusion
Rosetta(DE3)pLysS Rosetta(DE3)pLysS SHuffle C3030
proTHI2.1 1.4 3.1 3.7
proTHI2.2 0.5 0.7 3.4
proTHI2.3 0.3 2.3 4
proTHI2.4 0.2 1.1 2.8
Fusion proteins were purified from 1 l of culture by Ni–NTA affinity chromatography Protein concentrations (all as mg/l) were
determined using BCA test
Fig. 2 Cytoplamic expression of proTHI-TRX fusion proteins
in strain C3030. For all fusion proteins, 1 ml of cell culture was
pelleted and dissolved in 100 ll sample buffer. 10 ll from this
extract and an equivalent amount for total soluble cytoplasmic
fractions were separated on Tricine/SDS gels. (M) Protein
marker, (1) un-induced crude extract, (2) induced crude extract,
(3) total soluble fraction taken after cell lysis by sonication,
(4) insoluble fraction after sonication. Red stars indicate the
25 kDa fusion protein
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thionin proproteins contained disulfide bridges, it was
advantageous not to use DTT during TEV digestion;
however, under these conditions all fusion proteins
were poorly digested (Fig. 4). Inclusion of glutathione
(0.3 mM oxidized/3 mM reduced) gave better diges-
tion although still not complete with less than half of
the fusion protein digested. Addition of DTT gave
better results than glutathione with only a small
amount of undigested fusion protein remaining.
Antibacterial activity of fusion proteins
THI2.1 has in planta antifungal activity (Epple et al.
1997) and conditioned medium from cells expressing
THI2.1 showed in vitro antimicrobial activity (Loeza-
A´ngeles et al. 2008). For several other thionins,
antimicrobial activity in vitro has also been reported
(Terras et al. 1993). Nothing is known yet about a
possible antimicrobial activity of any thionin propro-
tein and thus it is also not known if the fusion proteins
might have any activity. Antimicrobial activity of
fusion proteins between TRX and AMPs has been
reported (Wu et al. 2011) and could therefore not be
excluded and might have been the reason that
proTHI2.2 and proTHI2.4 fusion proteins were
expressed rather poorly. We, therefore, tested the
antibacterial activity of all TRX fusion proteins
in vitro against the E. coli Rosetta strain. As shown
in Supplementary Fig. 7, TRX itself did not inhibit the
growth of E. coli at the concentrations tested (up to
100 ug/ml). However, high concentrations of proTHI-
TRX fusion proteins showed clearly inhibitory activity
especially after 8 h. The strongest activity was found
for proTHI2.3-TRX which was inhibitory down to
25 lg/ml while the other thionin proprotein TRX
fusions were only active at around 50 lg/ml.
Discussion
Anti-microbial peptides (AMP) are difficult targets
for heterologous expression in microbial hosts due to
their intrinsic antibacterial and/or antifungal activity
(Li 2009). In addition, the majority of plant AMPs
contain disulfide bridges that are only formed under
oxidizing conditions. In E. coli, the most popular
microbial expression host, disulfide bridges are usu-
ally formed in the periplasm while the cytoplasm has
reducing activity (reviewed by Salinas et al. 2011). To
reduce the toxic activities of expressed proteins and/or
to increase their solubility, a variety of different fusion
partners have been used (reviewed by Terpe 2003).
One fusion partner that has repeatedly been shown to
enhance the solubility of fusion proteins is MBP.
However, using MBP as a fusion partner in the vector
pJOE-SP-MC, a derivative of the vector pJOE4905.1
(Motejadded and Altenbuchner 2009), we were unable
Fig. 3 Comparison of Ni–NTA purified proTHI-TRX fusion
proteins from strain C3030. a Coomassie Brilliant Blue staining.
b Western blot with anti-His tag antibody. Each well contained
3 lg protein. (M) Prestained protein marker, (1) proTHI2.1-
TRX, (2) proTHI2.2-TRX, (3) proTHI2.3-TRX, (4) proTHI2.4-
TRX
Fig. 4 Silver stained tricine/SDS gel showing proTHI-TRX
fusion proteins digested with TEV protease. Equal amounts
(3.5 ug) of proThi-TRX was loaded. (M) Prestained protein
marker, (TP) TEV protease, (1) undigested fusion protein,
(2) fusion protein fraction digested with TEV protease, (3) fusion
protein digested with TEV protease in the presence of
glutathione (0.3 mM oxidized/3 mM reduced), (4) fusion
proteins digested with TEV protease in the presence of 1 mM
DTT. Red stars show the TRX protein and black stars show the
thionin proproteins
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to express the four Arabidopsis thionin proproteins as
fusion proteins at useful levels in the periplasm.
A reason for this might have been a proteolytic
processing of the fusion proteins in the periplasm since
the size of the fusion proteins was lower than
expected. Another reason could have been that the
fusion proteins were not properly secreted because
they were misfolded and deposited in inclusion bodies,
as the pellet that remained after osmotic shock
contained the majority of the fusion proteins.
This result was somewhat surprising since we had
produced THI2.1 proprotein before as a fusion with
two protein As derived ZZ domains using the vector
pExSecl (Epple et al. 1997). A serine protease inhib-
itor, turkey ovomucoid third domain, was similarly
produced as a fusion with two IgG-binding Z domains
(Lu et al. 1997). Other disulfide bridge-containing
peptides have also been produced with other fusion
partners in the periplasm in soluble form. For instance,
the spider neurotoxic peptide Huwentoxin-I was
expressed in the E. coli periplasm as a fusion with
DsbC (Meng et al. 2011).
Since periplasmic expression did not produce unde-
graded fusion proteins, we tested cytoplasmic expres-
sion using two different E. coli strains, Rosetta(DE3)
pLysS and C3030. The presence of DsbC inside the
cytoplasm in the C3030 strain should allow better
expression of proteins containing disulfide bridges. In
all cases, proteins corresponding to the expected size of
the fusion proteins were detected after induction;
however, only part of it was soluble, sometimes only a
small part, indicating that most of the foreign protein
was deposited in inclusion bodies. The proTHI2.4
fusion protein especially could only be expressed at a
rather low level. The reason for the different effective-
ness in producing the thionin proproteins was not clear
and we therefore tested the activity of all fusion proteins
against E. coli because we reasoned that different
toxicity of the fusion proteins could lead to differences
in expression level. Indeed, we found significant activity
of the proTHI fusion proteins on the growth of E. coli at
higher concentrations. However, the strongest activity
was found for the proTHI2.3-TRX fusion protein,
indicating that toxic effects might not be the primary
factor determining the expression level. On the other
hand, we cannot exclude that the proTHI-TRX fusion
proteins might have a different effect if produced inside
the cell. Another difference between proTHI2.4 and the
other proproteins is the pI which is strongly acidic (4.41)
while the other three thionin proproteins have a pI above
7 (Table S3). Thus, the reason for the different efficiency
in expressing the thionin proprotein fusion proteins
remains unclear at the moment.
The TRX fusion proteins contained a TEV recog-
nition site to release the thionin proproteins. It was
originally assumed that Gly or Ser are required in the
P10 position of the TEV protease recognition site
(Dougherty et al. 1988). The thionin proproteins have
Lys or Asn at the N-terminus which would have
required adding an additional amino acid, something
that we do not accept for AMPs or their proproteins
because it is not known if such an additional amino acid
would have an effect on the activity. However, it has
been shown that the requirement for Gly or Ser in the
P10-position is not that strict and that almost any amino
acid is to some degree accepted (Kapust et al. 2002).
We therefore designed the TEV recognition sequence
in such a way that the N-terminal amino acid of the
thionin proprotein would be in the P10-position of
theTEV recognition site. Indeed, digestion of the TRX
fusion proteins with TEV protease was successful for
all four proproteins, although it was necessary to
include DTT or glutathione. Inclusion of glutathione
(0.3 mM oxidized/3 mM reduced) resulted in almost
half of the fusion protein being digested. This was less
than obtained with 1 mmol DTT; however, inclusion
of DTT might lead to an opening of disulfide bridges
and an inactivation of the proproteins. Thus, the
production of proTHI-TRX fusion proteins and diges-
tion with TEV protease would allow us to produce
enough bona fide proproteins for further studies.
Conclusions
Periplasmic expression seems to be the natural choice
for the production of disulfide bridge containing
proteins in E. coli. However, we have shown here
that in case of thionin proproteins the expression as
TRX fusion proteins in the cytoplasm of the E. coli
strain C3030 was the method of choice.
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